Intracranial Aneurysm Market Overview

According to fortune business insights, the global intracranial aneurysm market size was valued at USD 1.74 billion in 2025 and is projected to grow from USD 1.87 billion in 2026 to USD 2.95 billion by 2034, exhibiting a CAGR of 5.90% during the forecast period. North America dominated the market with a share of 43.70% in 2025.

An intracranial aneurysm is a balloon-like growth in a blood vessel wall. Ruptures can cause life-threatening bleeding. Treatment focuses on preventing future ruptures through methods like microsurgical clipping, endovascular coiling, and flow diversion. The market is driven by increasing awareness, a rising number of patients with cerebrovascular diseases, and active R&D by market players to introduce novel treatment devices. According to the Brain Aneurysm Foundation, an estimated 6.7 million people in the U.S. have an unruptured brain aneurysm. The COVID-19 pandemic negatively impacted the market by causing a decline in procedural volumes.

Major Players Profiled in the Market Report:

  • Medtronic (Ireland)
  • B. Braun SE (Germany)
  • Integra LifeSciences (U.S.)
  • MicroPort Scientific Corporation (China)
  • Stryker (U.S.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Terumo Corporation (MicroVention Inc.) (Japan)
  • Evasc Neurovascular Enterprises (Canada)
  • Penumbra, Inc. (U.S.)

Latest Trends

Growing Preference Toward Minimal Invasive Procedures and Technological Advancement
There is a significant shift in patient preference from traditional open surgery (craniotomy) to minimally invasive procedures like coiling and stenting. These modern techniques, which include flow diverters, divert blood flow away from the aneurysm without opening the skull, resulting in reduced physical trauma and faster recovery times. The positive outcomes and safety profile of these novel devices are encouraging market players to introduce more technologically advanced products.

Drivers & Restraints

Increasing Prevalence of Cerebral Aneurysm to Augment Market Growth
A key driver for the market is the rising prevalence of cerebral aneurysms globally. Advances in imaging techniques like 3-D angiography are leading to more timely diagnoses, increasing the patient population seeking treatment. The positive clinical outcomes of devices used in minimally invasive procedures, such as coils and flow diverters, are further expected to drive market growth.

Strong Emphasis on Brain Aneurysm Research to Drive Market Growth
Growing support from public and private organizations for brain aneurysm research is another significant growth factor. Government grants and industry-led clinical studies are fueling the development and launch of novel medical devices, expanding treatment options and propelling market demand. For example, in July 2023, MicroVention, Inc. published 5-year follow-up data for its WEB Aneurysm Embolization System.

Misdiagnosis and Associated Costs May Restrict Market Growth
Despite the availability of advanced imaging, misdiagnosis or delayed diagnosis of ruptured aneurysms remains a challenge, particularly in emerging countries. Furthermore, the cost of treating a ruptured aneurysm is significantly higher than an unruptured one. These factors, combined with a lack of established clinical guidelines in some regions, may limit the adoption of treatment solutions and restrain market growth.

For detailed market insights: https://www.fortunebusinessinsights.com/intracranial-aneurysm-market-109526

Segments

Aneurysm Therapeutic Devices Segment to Dominate by Product Type
Based on product type, the market is segmented into aneurysm therapeutic devices, embolization devices, aspiration devices, and access devices. The aneurysm therapeutic devices segment (including clips, coils, and flow diverters) dominated the market with a projected 44.39% share in 2026. This is due to the high adoption of these devices in minimally invasive procedures, which have demonstrated positive clinical outcomes.

Saccular Aneurysm Segment to Lead by Type
By type, the market includes saccular, fusiform, and mycotic aneurysms. The saccular aneurysm segment is expected to capture the largest share (90.91%) in 2026. This dominance is attributed to the high prevalence of this type, which accounts for 80-90% of all brain aneurysms, driving the demand for corresponding medical devices.

Hospitals Segment to Dominate by End-User
Based on end-user, the market is divided into hospitals, specialty clinics, and others. The hospitals segment held the dominant share with a projected 72.19% in 2026. This is due to the higher adoption of advanced medical devices, the availability of skilled healthcare professionals, and a high volume of procedures performed in these settings.

Regional Insights

North America to Dominate the Global Market
North America accounted for 43.70% of the global market in 2025. The region's growth is driven by the strong presence of key market players, the availability of technologically advanced products, and continuous initiatives by public and private entities to promote early diagnosis and treatment.

Europe to Hold Second Position
Europe captured 29.90% of global revenue in 2025. The market is driven by increasing funding for clinical research, which is surging the demand for aneurysm therapeutic products across the region.

Asia Pacific to Witness Highest Growth
Asia Pacific is projected to expand at the highest CAGR during the forecast period. The high prevalence of intracranial aneurysms in countries like Japan and the comparatively lower cost of surgery in countries like India are expected to drive significant demand.

Latin America and the Middle East & Africa to Grow at a Slower Pace
These regions are expected to grow at a comparatively lower CAGR. Slower growth is attributed to a lack of well-established healthcare infrastructure and clinical guidelines for early diagnosis and treatment.

Competitive Landscape

Stryker, Medtronic, and Terumo Corporation Dominate with Strong Product Offerings
The market is dominated by Stryker, Medtronic, and Terumo Corporation, which maintain a strong global presence through robust product portfolios and strategic initiatives. For example, in May 2023, Stryker acquired Cerus Endovascular Ltd. to expand its aneurysm treatment solutions. Other prominent players like B. Braun SE and MicroPort Scientific Corporation are focusing on partnerships, while emerging companies such as Evasc Neurovascular and Penumbra, Inc. are actively investing in R&D to strengthen their market position.

Key Industry Development

  • June 2023: Fluid Biomedical Inc. launched its first-in-human clinical study with ReSolv, a polymer-based flow-diverting stent for brain aneurysms.
  • August 2022: Wallaby Medical signed an exclusive distribution agreement with Japan Lifeline Co., Ltd. to distribute its neurovascular treatment devices in Japan.
  • June 2022: Medtronic India launched a CE-marked flow diverter for the endovascular treatment of brain aneurysms in India.
  • June 2022: Stryker partnered with Carmeda to combine its flow diverter technology with Carmeda’s active heparin coating for treating brain aneurysms.
  • December 2021: Wallaby Medical, in partnership with Japan Lifeline Co., Ltd., launched the Avenir Coil System in Japan for embolizing intracranial aneurysms.

Report Coverage

The market report provides a detailed analysis and overview. It focuses on key aspects such as:

  • Competitive landscape
  • Product type, end-user, and regional analysis
  • Market drivers, trends, and dynamics
  • Impact of COVID-19 on the market
  • Other key insights that have contributed to the market's growth over recent years.

What Everyone Should Know About Japan’s Market Intracranial Aneurysm Market Insights

Add as a preferred source on Google